Effects of octreotide on glucose transporter type 2 expression in obese rat small intestine

World Journal of Gastroenterology

Volumn 17, Issue 39, 2011, Pages 4434-4439

  Wei, Na ^a   Liu, Rui ^a   Ou, Yan ^a   Li, Xian ^a   Qiang, Ou ^a   Guo, Wei ^a   Tang, Cheng Wei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Glucose transporter type 2; High fat diet; Maltase; Obesity; Octreotide; Rat; Small intestinal absorption

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 2; MALTOSE; MESSENGER RNA; OCTREOTIDE; SUCRASE;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFICACY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INJECTION; INTESTINE MUCOSA; LIPID DIET; MALE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE; TREATMENT DURATION; WESTERN BLOTTING;

EID: 81755181921     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i39.4434     Document Type: Article

References (26)

1. Wang SN, Lee KT, Ker CG. Leptin in hepatocellular carcinoma. World J Gastroenterol 2010; 16: 5801-5809
2. Hansen PA, Han DH, Marshall BA, Nolte LA, Chen MM, Mueckler M, Holloszy JO. A high fat diet impairs stimulation of glucose transport in muscle. Functional evaluation of potential mechanisms. J Biol Chem 1998; 273: 26157-26163
3. Kellett GL, Brot-Laroche E, Mace OJ, Leturque A. Sugar absorption in the intestine: the role of GLUT2. Annu Rev Nutr 2008; 28: 35-54
4. Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C. Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov 2003; 2: 999-1017
5. Foxx-Orenstein A, Camilleri M, Stephens D, Burton D. Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans. Gut 2003; 52: 1555-1561
6. Strosberg J, Kvols L. Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors. World J Gastroenterol 2010; 16: 2963-2970
7. Kang L, Routh VH, Kuzhikandathil EV, Gaspers LD, Levin BE. Physiological and molecular characteristics of rat hypo-thalamic ventromedial nucleus glucosensing neurons. Diabetes 2004; 53: 549-559
8. Lentze MJ. Molecular and cellular aspects of hydrolysis and absorption. Am J Clin Nutr 1995; 61: 946S-951S
9. Wright EM. I. Glucose galactose malabsorption. Am J Physiol 1998; 275: G879-G882
10. Ferraris RP. Dietary and developmental regulation of intestinal sugar transport. Biochem J 2001; 360: 265-276
11. Dunsford BR, Haensly WE. Effect of dietary cholesterol and carbohydrate on small intestinal structure and function in prematurely weaned rats. J Anim Sci 1991; 69: 2894-2903
12. Lostao MP, Berjón A, Barber A, Ponz F. On the multiplicity of glucose analogues transport systems in rat intestine. Rev Esp Fisiol 1991; 47: 209-216
13. Han DH, Hansen PA, Host HH, Holloszy JO. Insulin resistance of muscle glucose transport in rats fed a high-fat diet: a reevaluation. Diabetes 1997; 46: 1761-1767
14. Im SS, Kang SY, Kim SY, Kim HI, Kim JW, Kim KS, Ahn YH. Glucose-stimulated upregulation of GLUT2 gene is mediated by sterol response element-binding protein-1c in the hepatocytes. Diabetes 2005; 54: 1684-1691
15. Burcelin R, Eddouks M, Kande J, Assan R, Girard J. Evidence that GLUT-2 mRNA and protein concentrations are decreased by hyperinsulinaemia and increased by hyper-glycaemia in liver of diabetic rats. Biochem J 1992; 288 (Pt 2): 675-679
16. Thorens B. Glucose transporters in the regulation of intestinal, renal, and liver glucose fuxes. Am J Physiol 1996; 270: G541-G553
17. Leturque A, Brot-Laroche E, Le Gall M. GLUT2 mutations, translocation, and receptor function in diet sugar managing. Am J Physiol Endocrinol Metab 2009; 296: E985-E992
18. Kellett GL, Brot-Laroche E. Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes 2005; 54: 3056-3062
19. Tobin V, Le Gall M, Fioramonti X, Stolarczyk E, Blazquez AG, Klein C, Prigent M, Serradas P, Cuif MH, Magnan C, Le-turque A, Brot-Laroche E. Insulin internalizes GLUT2 in the enterocytes of healthy but not insulin-resistant mice. Diabetes 2008; 57: 555-562
20. Aydede H, Sakarya A, Erhan Y, Kara E, Ilkgul O, Ozdemir N. Effects of octreotide and propranolol on colonic mucosa in rats with portal hypertensive colopathy. Hepatogastroenterol-ogy 2003; 50: 1352-1355
21. Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S, Xiong X. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2003; 88: 2586-2592
22. Velasquez-Mieyer PA, Cowan PA, Arheart KL, Buffngton CK, Spencer KA, Connelly BE, Cowan GW, Lustig RH. Suppression of insulin secretion is associated with weight loss and altered macronutrient intake and preference in a subset of obese adults. Int J Obes Relat Metab Disord 2003; 27: 219-226
23. Williams C, Gowan R, Perey BJ. A Double-Blind Placebo-controlled Trial of Ursodeoxycholic Acid in the Prevention of Gallstones during Weight Loss after Vertical Banded Gas-troplasty. Obes Surg 1993; 3: 257-259
24. Strowski MZ, Parmar RM, Blake AD, Schaeffer JM. Soma-tostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology 2000; 141: 111-117
25. Cui XL, Jiang L, Ferraris RP. Regulation of rat intestinal GLUT2 mRNA abundance by luminal and systemic factors. Biochim Biophys Acta 2003; 1612: 178-185
26. Kleuss C, Hescheler J, Ewel C, Rosenthal W, Schultz G, Wittig B. Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature 1991; 353: 43-48